<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37083203</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-0496</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Pediatric pulmonology</Title><ISOAbbreviation>Pediatr Pulmonol</ISOAbbreviation></Journal><ArticleTitle>Lung function after SARS-CoV-2 infection: A prospective cohort study in children.</ArticleTitle><Pagination><StartPage>2009</StartPage><EndPage>2016</EndPage><MedlinePgn>2009-2016</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.26425</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Although impaired lung function after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been described in adults, it is unclear whether lung function might be altered in children, especially among asymptomatic or mildly symptomatic patients. In this study, we report the results of lung function testing performed after SARS-CoV-2 infection in a large pediatric population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study included 589 patients with previous confirmed SARS-CoV-2 infection aged 0-18 years. Both symptomatic and asymptomatic patients during acute infection were enrolled in the study. A spirometry was performed in all cooperating patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean age of enrolled patients was 9.6 years and the mean time from infection to enrollment was 171 days. Spirometry was performed and deemed evaluable in 433 patients. No patient had reduced forced vital capacity (FVC) and only 14 patients (3.2%) had a forced expiratory volume in the First second (FEV1)&#x2009;&lt;&#x2009;80%. The mean spirometry values recorded were in the normal range. There were no statistically significant differences in spirometry values between patients with respiratory symptoms during infection and those without. Similarly, there were no differences in spirometry parameters according to the time elapsed between infection and enrollment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Lung function, according to spirometry values, does not appear to be impaired long after infection in the pediatric population. The presence of respiratory symptoms during SARS-CoV-2 infection would not represent a risk factor for impaired lung function in this cohort of patients.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iovine</LastName><ForeName>Elio</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3024-9037</Identifier><AffiliationInfo><Affiliation>Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Mattia</LastName><ForeName>Greta</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nenna</LastName><ForeName>Raffaella</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8880-3462</Identifier><AffiliationInfo><Affiliation>Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Regina</LastName><ForeName>Domenico Paolo</ForeName><Initials>DP</Initials><Identifier Source="ORCID">0000-0002-8297-8920</Identifier><AffiliationInfo><Affiliation>Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancino</LastName><ForeName>Enrica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrarca</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2430-2981</Identifier><AffiliationInfo><Affiliation>Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conti</LastName><ForeName>Maria Giulia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matera</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virgili</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Midulla</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7476-5266</Identifier><AffiliationInfo><Affiliation>Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Long COVID Research Group</CollectiveName><AffiliationInfo><Affiliation>Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Pulmonol</MedlineTA><NlmUniqueID>8510590</NlmUniqueID><ISSNLinking>1099-0496</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014797" MajorTopicYN="N">Vital Capacity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005541" MajorTopicYN="N">Forced Expiratory Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="N">Spirometry</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword><Keyword MajorTopicYN="N">spirometry</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>7</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37083203</ArticleId><ArticleId IdType="doi">10.1002/ppul.26425</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>World Health Organization. Coronavirus disease (COVID-2019) situation reports. Situation report-1 January, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4</Citation></Reference><Reference><Citation>World Health Organization. Director-General's opening remarks at the media briefing on COVID-19. March, 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020</Citation></Reference><Reference><Citation>Parri N, Lenge M, Buonsenso D. Children with COVID-19 in pediatric emergency departments in Italy. N Engl J Med. 2020;383:187-190.</Citation></Reference><Reference><Citation>Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20:911-919.</Citation></Reference><Reference><Citation>G&#xf6;tzinger F, Santiago-Garc&#xed;a B, Noguera-Juli&#xe1;n A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4:653-661.</Citation></Reference><Reference><Citation>Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382:1663-1665.</Citation></Reference><Reference><Citation>Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021;27(4):328-337.</Citation></Reference><Reference><Citation>Mo X, Jian W, Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6):2001217.</Citation></Reference><Reference><Citation>Tamminen P, Kerimov D, Viskari H, Aittoniemi J, Syrj&#xe4;nen J, Lehtim&#xe4;ki L. Lung function during and after acute respiratory infection in COVID-19 positive and negative outpatients. Eur Respir J. 2022;59(3):2102837.</Citation></Reference><Reference><Citation>Choi JH, Choi SH, Yun KW. Risk factors for severe COVID-19 in children: A systematic review and meta-analysis. J Korean Med Sci. 2022;37(5):e35.</Citation></Reference><Reference><Citation>Nursoy MA, B&#xfc;lb&#xfc;l L, Yaz&#x131;c&#x131; M, et al. Comparison of clinical features of COVID-19 infection in children with asthma and their healthy peers. Pediatr Pulmonol. 2022:1693-1700.</Citation></Reference><Reference><Citation>Sanchez-Garcia S, Ruiz-Hornillos J, Bernaola-Abraira M, et al. Effect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma. Allergol Immunopathol. 2022;50(1):99-103.</Citation></Reference><Reference><Citation>Istituto Superiore di Sanit&#xe0; (ISS), Roma, 12 Novembre 2021- Prevalenza e distribuzione delle varianti di SARS-CoV-2 di interesse per la sanit&#xe0; pubblica in Italia. Rapporto n. 13 del 12 novembre 2021. https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-monitoraggio-varianti-rapporti-periodici-12-novembre-2021.pdf</Citation></Reference><Reference><Citation>WHO working group on the clinical characterisation and management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192-e197.</Citation></Reference><Reference><Citation>Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An official American thoracic society and european respiratory society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70-e88.</Citation></Reference><Reference><Citation>Quanjer PH, Stanojevic S, Cole TJ, et al. ERS Global Lung Function Initiative Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324-1343.</Citation></Reference><Reference><Citation>Truffaut L, Demey L, Bruyneel AV, et al. Post-discharge critical COVID-19 lung function related to severity of radiologic lung involvement at admission. Respir Res. 2021;22(1):29.</Citation></Reference><Reference><Citation>Ordinola Navarro A, Cervantes-Bojalil J, Cobos Quevedo OJ, et al. Decreased quality of life and spirometric alterations even after mild-moderate COVID-19. Respir Med. 2021;181:106391.</Citation></Reference><Reference><Citation>Eksombatchai D, Wongsinin T, Phongnarudech T, Thammavaranucupt K, Amornputtisathaporn N, Sungkanuparph S. Pulmonary function and six-minute-walk test in patients after recovery from COVID-19: a prospective cohort study. PLoS One. 2021;16(9):e0257040.</Citation></Reference><Reference><Citation>Istituto Superiore di Sanit&#xe0; (ISS), Roma, 1 Dicembre 2021- Epidemia COVID-19 aggiornamento nazionale - 01 Dicembre 2021. https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_1-dicembre-2021.pdf</Citation></Reference><Reference><Citation>Bottino I, Patria MF, Milani GP, et al. Can asymptomatic or Non-Severe SARS-CoV-2 infection cause medium-term pulmonary sequelae in children? Front Pediatr. 2021;9:621019.</Citation></Reference><Reference><Citation>Lund Berven L, Selvakumar J, Havdal L, et al. Inflammatory markers, pulmonary function, and clinical symptoms in acute COVID-19 among non-hospitalized adolescents and young adults. Front Immunol. 2022;13:837288.</Citation></Reference><Reference><Citation>Leftin Dobkin SC, Collaco JM, McGrath-Morrow SA. Protracted respiratory findings in children post-SARS-CoV-2 infection. Pediatr Pulmonol. 2021;56(12):3682-3687.</Citation></Reference><Reference><Citation>Selroos O, Kupczyk M, Kuna P, et al. National and regional asthma programmes in Europe. Eur Respir Rev. 2015;24(137):474-483.</Citation></Reference><Reference><Citation>Adir Y, Saliba W, Beurnier A, Humbert M. Asthma and COVID-19: an update. Eur Respir Rev. 2021;30(162):210152.</Citation></Reference><Reference><Citation>Caminati M, Lombardi C, Micheletto C, et al. Asthmatic patients in COVID-19 outbreak: few cases despite many cases. J Allergy Clin Immunol. 2020;146(3):541-542.</Citation></Reference><Reference><Citation>Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol. 2020;146(6):1295-1301.</Citation></Reference><Reference><Citation>Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009.</Citation></Reference><Reference><Citation>Nikolopoulou GB, Maltezou HC. COVID-19 in children: where do we stand? Arch Med Res. 2022;53(1):1-8.</Citation></Reference><Reference><Citation>Cristiani L, Mancino E, Matera L, et al. Will children reveal their secret? The coronavirus dilemma. Eur Respir J. 2020;55(4):2000749.</Citation></Reference><Reference><Citation>Knoke L, Schlegtendal A, Maier C, Eitner L, L&#xfc;cke T, Brinkmann F. Pulmonary function and long-term respiratory symptoms in children and adolescents after COVID-19. Front Pediatr. 2022;10:851008.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>